Abstract
Mulberry leaves are rich in 1-deoxynojirimycin (DNJ), an inhibitor of α-glucosidase. We previously showed that DNJ-rich mulberry leaf extract suppressed elevation of postprandial blood glucose in humans. The objective of this study was to evaluate the effects of DNJ-rich mulberry leaf extract on plasma lipid profiles in humans. An open-label, single-group study was conducted in 10 subjects with initial serum triglyceride (TG) level ≥200 mg/dl. Subjects ingested capsules containing DNJ-rich mulberry leaf extract at 12 mg three times daily before meals for 12 weeks. Our findings showed a modest decrease in serum TG level and beneficial changes in the lipoprotein profile following 12-week administration of DNJ-rich mulberry leaf extract. No significant changes in hematological or biochemical parameters were observed during the study period; no adverse events associated with DNJ-rich mulberry leaf extract occurred.
Original language | English |
---|---|
Pages (from-to) | 155-161 |
Number of pages | 7 |
Journal | Journal of Clinical Biochemistry and Nutrition |
Volume | 47 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2010 Sept |
Keywords
- 1-deoxynojirimycin
- Mulberry leaf extract
- Serum lipid profile
- Serum triglyceride